These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 9420244)

  • 1. Mucosal and parenteral vaccination against acute and latent murine cytomegalovirus (MCMV) infection by using an attenuated MCMV mutant.
    MacDonald MR; Li XY; Stenberg RM; Campbell AE; Virgin HW
    J Virol; 1998 Jan; 72(1):442-51. PubMed ID: 9420244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of murine cytomegalovirus (MCMV) replication with a DNA vaccine encoding MCMV M84 (a homolog of human cytomegalovirus pp65).
    Morello CS; Cranmer LD; Spector DH
    J Virol; 2000 Apr; 74(8):3696-708. PubMed ID: 10729145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic priming-boosting immunization with a trivalent plasmid DNA and inactivated murine cytomegalovirus (MCMV) vaccine provides long-term protection against viral replication following systemic or mucosal MCMV challenge.
    Morello CS; Ye M; Hung S; Kelley LA; Spector DH
    J Virol; 2005 Jan; 79(1):159-75. PubMed ID: 15596812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a vaccine against murine cytomegalovirus (MCMV), consisting of plasmid DNA and formalin-inactivated MCMV, that provides long-term, complete protection against viral replication.
    Morello CS; Ye M; Spector DH
    J Virol; 2002 May; 76(10):4822-35. PubMed ID: 11967299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nasal peptide vaccination elicits CD8 responses and reduces viral burden after challenge with virulent murine cytomegalovirus.
    Gopal IN; Quinn A; Henry SC; Hamilton JD; Staats HF; Frothingham R
    Microbiol Immunol; 2005; 49(2):113-9. PubMed ID: 15722596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunisation of Balb/c mice with severely attenuated murine cytomegalovirus mutants induces protective cellular and humoral immunity.
    Morley PJ; Ertl P; Sweet C
    J Med Virol; 2002 Jun; 67(2):187-99. PubMed ID: 11992579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective MCMV immunity by vaccination of the salivary gland via Wharton's duct: replication-deficient recombinant adenovirus expressing individual MCMV genes elicits protection similar to that of MCMV.
    Liu G; Zhang F; Wang R; London L; London SD
    FASEB J; 2014 Apr; 28(4):1698-710. PubMed ID: 24391133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Murine cytomegalovirus with a deletion of genes spanning HindIII-J and -I displays altered cell and tissue tropism.
    Cavanaugh VJ; Stenberg RM; Staley TL; Virgin HW; MacDonald MR; Paetzold S; Farrell HE; Rawlinson WD; Campbell AE
    J Virol; 1996 Mar; 70(3):1365-74. PubMed ID: 8627652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon gamma regulates acute and latent murine cytomegalovirus infection and chronic disease of the great vessels.
    Presti RM; Pollock JL; Dal Canto AJ; O'Guin AK; Virgin HW
    J Exp Med; 1998 Aug; 188(3):577-88. PubMed ID: 9687534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple epitopes in the murine cytomegalovirus early gene product M84 are efficiently presented in infected primary macrophages and contribute to strong CD8+-T-lymphocyte responses and protection following DNA immunization.
    Ye M; Morello CS; Spector DH
    J Virol; 2004 Oct; 78(20):11233-45. PubMed ID: 15452242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mucosal CD8+ T cell responses induced by an MCMV based vaccine vector confer protection against influenza challenge.
    Zheng X; Oduro JD; Boehme JD; Borkner L; Ebensen T; Heise U; Gereke M; Pils MC; Krmpotic A; Guzmán CA; Bruder D; Čičin-Šain L
    PLoS Pathog; 2019 Sep; 15(9):e1008036. PubMed ID: 31525249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunization with a murine cytomegalovirus based vector encoding retrovirus envelope confers strong protection from Friend retrovirus challenge infection.
    Bongard N; Le-Trilling VTK; Malyshkina A; Rückborn M; Wohlgemuth K; Wensing I; Windmann S; Dittmer U; Trilling M; Bayer W
    PLoS Pathog; 2019 Sep; 15(9):e1008043. PubMed ID: 31568492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hematopoietic cell-mediated dissemination of murine cytomegalovirus is regulated by NK cells and immune evasion.
    Zhang S; Springer LE; Rao HZ; Espinosa Trethewy RG; Bishop LM; Hancock MH; Grey F; Snyder CM
    PLoS Pathog; 2021 Jan; 17(1):e1009255. PubMed ID: 33508041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted deletion of regions rich in immune-evasive genes from the cytomegalovirus genome as a novel vaccine strategy.
    Cicin-Sain L; Bubić I; Schnee M; Ruzsics Z; Mohr C; Jonjić S; Koszinowski UH
    J Virol; 2007 Dec; 81(24):13825-34. PubMed ID: 17913824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strong CD8 T-cell responses following coimmunization with plasmids expressing the dominant pp89 and subdominant M84 antigens of murine cytomegalovirus correlate with long-term protection against subsequent viral challenge.
    Ye M; Morello CS; Spector DH
    J Virol; 2002 Mar; 76(5):2100-12. PubMed ID: 11836387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An adjuvanted inactivated murine cytomegalovirus (MCMV) vaccine induces potent and long-term protective immunity against a lethal challenge with virulent MCMV.
    Wang H; Yao Y; Huang C; Fu X; Chen Q; Zhang H; Chen J; Fang F; Xie Z; Chen Z
    BMC Infect Dis; 2014 Apr; 14():195. PubMed ID: 24720840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA immunization confers protection against murine cytomegalovirus infection.
    González Armas JC; Morello CS; Cranmer LD; Spector DH
    J Virol; 1996 Nov; 70(11):7921-8. PubMed ID: 8892915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An attenuated temperature-sensitive strain of cytomegalovirus (tsm5) establishes immunity without development of CD8(+) T cell memory inflation.
    Beswick M; Pachnio A; Al-Ali A; Sweet C; Moss PA
    J Med Virol; 2013 Nov; 85(11):1968-74. PubMed ID: 23852921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of host genotype in determining the relative roles of natural killer cells and T cells in mediating protection against murine cytomegalovirus infection.
    Lathbury LJ; Allan JE; Shellam GR; Scalzo AA
    J Gen Virol; 1996 Oct; 77 ( Pt 10)():2605-13. PubMed ID: 8887497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Murine cytomegalovirus (CMV) infection via the intranasal route offers a robust model of immunity upon mucosal CMV infection.
    Oduro JD; Redeker A; Lemmermann NAW; Ebermann L; Marandu TF; Dekhtiarenko I; Holzki JK; Busch DH; Arens R; Čičin-Šain L
    J Gen Virol; 2016 Jan; 97(1):185-195. PubMed ID: 26555192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.